ELMD · Electromed, Inc.
$41.22
-1.32 (-3.10%)
At close · Aug 14
Market Cap
$341.30M
Shares
8.28M
Electromed, Inc. Earnings Call Transcripts
Every quarterly earnings call for Electromed, Inc. (ELMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲6.6%
$10.66M
$81,000
'23 Q1
22-11-08
▲14.5%
$11.73M
$977,000
'23 Q2
23-02-14
▲19%
$12.07M
$1.07M
'23 Q3
23-05-09
▲20.8%
$13.61M
$1.03M
'23 Q4
23-08-22
▲15.6%
$12.32M
$155,000
'24 Q1
23-11-07
▲16.7%
$13.69M
$1.67M
'24 Q2
24-02-13
▲14.9%
$13.87M
$1.49M
'24 Q3
24-05-07
▲9%
$14.83M
$1.83M
'24 Q4
24-08-27
▲19%
$14.67M
$1.47M
'25 Q1
24-11-12
▲18.7%
$16.25M
$1.97M
'25 Q2
25-02-11
▲13.1%
$15.68M
$1.89M
'25 Q3
25-05-13
▲17.3%
$17.39M
$2.20M
'25 Q4
25-08-26
▲15.1%
$16.89M
$2.14M
'26 Q1
25-11-12
▲16.3%
$18.90M
$2.76M
'26 Q2
26-02-10
LATEST
▲18.4%
$18.57M
$3.00M
'26 Q3
26-05-12
Earnings call
FY26 · Q4
2026-08-25
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-05-12
Electromed, Inc. Q3 FY2026 Earnings Call
Confident tone
Bronchiectasis market opportunity
Revenue and profit growth
Clinical education and awareness campaigns
Revenue
$18.57M
▲ 18.4% YoY Diluted EPS
$0.35
▲ 66.7% YoY Gross margin
78.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-02-10
Electromed, Inc. Q2 FY2026 Earnings Call
Confident tone
Bronchiectasis market opportunity
Sales channel performance
Capital allocation
Revenue
$18.90M
▲ 16.3% YoY Diluted EPS
$0.32
▲ 45.5% YoY Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-11-12
Electromed, Inc. Q1 FY2026 Earnings Call
Confident tone
Revenue and earnings growth
Channel performance (home care, distributor, hospital)
Bronchiectasis market opportunity
Revenue
$16.89M
▲ 15.1% YoY Diluted EPS
$0.25
▲ 56.2% YoY Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-08-26
Electromed, Inc. Q4 FY2025 Earnings Call
Confident tone
Revenue growth across all segments
Bronchiectasis market opportunity
Operational efficiency and technology
Revenue
$17.39M*
▲ 17.3% YoY Gross margin
78.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-05-13
Electromed, Inc. Q3 FY2025 Earnings Call
Confident tone
Revenue and earnings growth
Bronchiectasis awareness and market development
Sales force expansion
Revenue
$15.68M
▲ 13.1% YoY Diluted EPS
$0.21
▲ 23.5% YoY Gross margin
78.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-02-11
Electromed, Inc. Q2 FY2025 Earnings Call
Revenue
$16.25M
▲ 18.7% YoY Diluted EPS
$0.22
▲ 15.8% YoY Gross margin
77.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-11-12
Electromed, Inc. Q1 FY2025 Earnings Call
Confident tone
Revenue Growth
SmartVest Clearway / Bronchiectasis Awareness
Natural Disaster Risk Monitoring
Revenue
$14.67M
▲ 19% YoY Diluted EPS
$0.16
▲ 700% YoY Gross margin
78.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-08-27
Electromed, Inc. Q4 FY2024 Earnings Call
Confident tone
Bronchiectasis market development
SmartVest Clearway and product initiatives
Insmed drug competitive landscape
Revenue
$14.83M*
▲ 9% YoY Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-05-07
Electromed, Inc. Q3 FY2024 Earnings Call
Confident tone
Bronchiectasis market opportunity
Change Healthcare cyberattack
Revenue growth and record results
Revenue
$13.87M
▲ 14.9% YoY Diluted EPS
$0.17
▲ 41.7% YoY Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-02-13
Electromed, Inc. Q2 FY2024 Earnings Call
Confident tone
Market opportunity in bronchiectasis
Hospital and distribution partnerships
Sales force expansion
Revenue
$13.69M
▲ 16.7% YoY Diluted EPS
$0.19
▲ 72.7% YoY Gross margin
77.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-11-07
Electromed, Inc. Q1 FY2024 Earnings Call
Revenue
$12.32M
▲ 15.6% YoY Diluted EPS
$0.02
▲ 100% YoY Gross margin
77.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-08-22
Electromed, Inc. Q4 FY2023 Earnings Call
Revenue
$13.61M*
▲ 20.8% YoY Gross margin
76.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-05-09
Electromed, Inc. Q3 FY2023 Earnings Call
Revenue
$12.07M
▲ 19% YoY Diluted EPS
$0.12
▲ 71.4% YoY Gross margin
75.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-02-14
Electromed, Inc. Q2 FY2023 Earnings Call
Revenue
$11.73M
▲ 14.5% YoY Diluted EPS
$0.11
▲ 10% YoY Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-11-08
Electromed, Inc. Q1 FY2023 Earnings Call
Revenue
$10.66M
▲ 6.6% YoY Diluted EPS
$0.01
▼ 80% YoY Gross margin
78.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-08-23
Electromed, Inc. Q4 FY2022 Earnings Call
Revenue
$11.27M*
▲ 19% YoY Gross margin
72.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-05-10
Electromed, Inc. Q3 FY2022 Earnings Call
Revenue
$10.14M
▲ 15.4% YoY Diluted EPS
$0.07
▲ 133.3% YoY Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-02-08
Electromed, Inc. Q2 FY2022 Earnings Call
Revenue
$10.25M
▲ 7.9% YoY Diluted EPS
$0.10
▼ 23.1% YoY Gross margin
76.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-11-09
Electromed, Inc. Q1 FY2022 Earnings Call
Revenue
$10.00M
▲ 25% YoY Diluted EPS
$0.05
▼ 16.7% YoY Gross margin
77.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-08-09
Electromed, Inc. Q4 FY2021 Earnings Call
Revenue
$9.47M*
▲ 37.7% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-05-11
Electromed, Inc. Q3 FY2021 Earnings Call
Revenue
$8.79M
▲ 0.5% YoY Diluted EPS
$0.03
▼ 57.1% YoY Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-02-09
Electromed, Inc. Q2 FY2021 Earnings Call
Revenue
$9.50M
▲ 11.1% YoY Diluted EPS
$0.13
▼ 7.1% YoY Gross margin
79.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-11-10
Electromed, Inc. Q1 FY2021 Earnings Call
Revenue
$8.00M
▼ 3.6% YoY Diluted EPS
$0.06
▼ 50% YoY Gross margin
76.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-08-25
Electromed, Inc. Q4 FY2020 Earnings Call
Revenue
$6.88M*
▼ 20.1% YoY Gross margin
81.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-05-12
Electromed, Inc. Q3 FY2020 Earnings Call
Revenue
$8.74M
▲ 18% YoY Diluted EPS
$0.07
▲ 75% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-02-11
Electromed, Inc. Q2 FY2020 Earnings Call
Revenue
$8.55M
▲ 6.7% YoY Diluted EPS
$0.14
▲ 250% YoY Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-09-30
Electromed, Inc. Q1 FY2020 Earnings Call
Revenue
$8.30M
▲ 14.1% YoY Diluted EPS
$0.12
▲ 500% YoY Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–28 of 28 earnings calls
Key facts
CIK
1488917
CUSIP
285409108
13F (30d)
125 filings
120 filers
Visit website
Investor relations